Organogenesis HoldingsFRA:2PQ -2.83%65 OCF Yield % is 9.82 as of Jul. 03, 2026, which is 2876% above its 10-year median of 0.33. GuruFocus rates FRA:2PQ with a GF Score™ of 65/100 and a GF Value™ of €2.68 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,007 Drug Manufacturers companies, Organogenesis Holdings ranks better than 79.34% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Organogenesis Holdings OCF Yield % Related Terms
Organogenesis Holdings OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:2PQ vs TKNO, AKBA, SIGA: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Organogenesis Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Organogenesis Holdings OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Organogenesis Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Organogenesis Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Organogenesis Holdings (FRA:2PQ) has a OCF Yield % of 9.82 as of Jul. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Organogenesis Holdings and its competitors. This is 2876% above median its historical median of 0.33. According to the industry distribution chart, Organogenesis Holdings ranks #208 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 20.7%.
Is Organogenesis Holdings' OCF Yield % too high?
Organogenesis Holdings' current OCF Yield % of 9.82 is 2876% above median its 10-year median of 0.33. The Drug Manufacturers industry median OCF Yield % is 3.43. Organogenesis Holdings' value of 9.82 is 186.3% above this industry median. Based on the distribution chart, Organogenesis Holdings ranks #208 out of 1007 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Organogenesis Holdings has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Organogenesis Holdings' OCF Yield % compare to TKNO and AKBA?
According to the Drug Manufacturers industry distribution chart, Organogenesis Holdings ranks #208 out of 1007 companies for OCF Yield %. This places Organogenesis Holdings in the top 21% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.43. Organogenesis Holdings' value of 9.82 is 186.3% above this benchmark. While the company's 10-year median is 0.33 vs. the industry median of 3.43, Organogenesis Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.43, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Organogenesis Holdings's current OCF Yield % of 9.82 is 186.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Organogenesis Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Organogenesis Holdings's current OCF Yield % is 9.82, which is 2876% above median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organogenesis Holdings stock overvalued right now?
Based on GuruFocus' analysis, Organogenesis Holdings (FRA:2PQ) is currently considered Modestly Undervalued. The stock's GF Value™ is €2.68, compared to a current price of €2.06 — trading 23.1% below its estimated fair value. The current OCF Yield % is 9.82, which is 2876% above median its 10-year median of 0.33 and 186.3% above the Drug Manufacturers industry median of 3.43. Organogenesis Holdings' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Organogenesis Holdings (FRA:2PQ), the current OCF Yield % is 9.82 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Organogenesis Holdings (FRA:2PQ) Overvalued in 2026?
Based on GuruFocus' analysis, Organogenesis Holdings stock appears to be undervalued.
The current stock price of €2.06 is trading 23.1% below its estimated GF Value™ of €2.68.
GuruFocus considers Organogenesis Holdings to be Modestly Undervalued.
Key valuation signals for FRA:2PQ:
OCF Yield %: 9.82 (2876% above median its 10-year median of 0.33)
GF Value™: €2.68 vs. price of €2.06 (23.1% below fair value)
Industry Position: 186.3% above the Drug Manufacturers median (#208 of 1007)
No single metric tells the full story. See the FRA:2PQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
65GF Score
Get the complete analysis for FRA:2PQ
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2PQ has been successfully added to your 
